Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 Next >
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Tags Companies Health care industry Pharmaceuticals
From CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
Tags Markets Europe News Zealand Pharma A/S
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Novo Nordisk A/S Eli Lilly and Co Labor economy
From CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Tags Companies Health care industry Business
From CNBC.com News
European stocks set for muted open after European Central Bank cut
Tags Novo Nordisk A/S Voting Europe Economy
From CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
Tags Small Business Health Insurance Business News
From CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
Tags Eli Lilly and Co US: News Novo Nordisk A/S
From CNBC.com News
Cramer's Lightning Round: Apple is a buy
Tags Tegna Inc Investment Strategy Business News
From CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
Tags Biotech and Pharmaceuticals Finance Breaking News: Investing
From CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
Tags Technology Internet Health care industry
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
Tags Uber Technologies Inc Eli Lilly and Co Novo Nordisk A/S
From CNBC.com News
AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines
Tags Novo Nordisk A/S Business News World News
From CNBC.com News
Hims & Hers Health adds compounded GLP-1 injections to weight loss program
Tags Breaking News: Technology Enterprise Business News
From CNBC.com News
Roche says weight loss drug shows promising results in early trial
Tags Health & Science Pharmaceuticals Roche Holding AG
From CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
Tags Health & Science Healthy Returns Health care industry
From CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
Tags Pharmaceuticals Health & Science Social issues
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
Tags Apple Inc Biotech and Pharmaceuticals Eli Lilly and Co
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Tags Business Health care industry Zealand Pharma A/S
From CNBC.com News
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
Tags Business Health care industry Companies
From CNBC.com News
Amgen scraps experimental weight loss pill, moves forward with injection
Tags Novo Nordisk A/S US: News Eli Lilly and Co
From CNBC.com News
Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double
Tags Earnings Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
Tags Business GSK plc Health care industry
From CNBC.com News
Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.
Tags Policy Health care industry Breaking News: Politics
From CNBC.com News
More than 3 million Medicare patients could be eligible for coverage of Wegovy to reduce heart disease risks, study says
Tags Social issues Biotechnology Biotech and Pharmaceuticals
From CNBC.com News
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
Tags Vital Farms Inc Simply Good Foods Co Business
From CNBC.com News
Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says
Tags Business News Biotechnology Biotech and Pharmaceuticals
From CNBC.com News
Eli Lilly’s Zepbound shows promise as a sleep apnea treatment in late-stage trials
Tags Pharmaceuticals Health & Science US: News
From CNBC.com News
EU probe of weight loss and diabetes drugs like Wegovy, Ozempic finds no link to suicidal thoughts
Tags Business News Biotechnology Biotech and Pharmaceuticals
From CNBC.com News
Diabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trial
Tags Novo Nordisk A/S Eli Lilly and Co US: News
From CNBC.com News
Danone CEO downplays threat of weight loss drugs on food producers: 'We see ourselves as extremely complementary'
Tags Food and Beverage Health & Science Business
From CNBC.com News
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.